ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

DCT To Announce Three New CRAGs

November 12, 1976

Breast Cancer Task Force Suggests 12 New Projects For RFPs, Hears Report On Hormones

January 16, 1976

Reynolds Unveils New Cigarette ; Cullen, Others Skeptical

September 18, 1987